Impact of choice of imaging modality accompanying outpatient exercise stress testing on outcomes and resource use after revascularization for acute coronary syndromes by Federspiel, Jerome J. et al.
Impact of choice of imaging modality accompanying outpatient
exercise stress testing on outcomes and resource use after
revascularization for acute coronary syndromes
Jerome J. Federspiel, PhDa,b,c, Bimal R. Shah, MD, MBAa,d, Leslee J. Shaw, PhDe,
Frederick A. Masoudi, MD, MSPHf, Patricia P. Chang, MD, MHSc, Sally C. Stearns, PhDb,
Daniel W. Mudrick, MD, MPHd,g, Patricia A. Cowper, PhDa, Cynthia L. Green, PhDa, and
Pamela S. Douglas, MDa,d
aDuke Clinical Research Institute, Durham, NC
bUNC Gillings School of Global Public Health, Chapel Hill, NC
cUniversity of North Carolina School of Medicine, Chapel Hill, NC
dDuke University School of Medicine, Durham, NC
eEmory University, Atlanta, GA
fAnschutz Medical Campus, University of Colorado, Aurora, CO
gMcConnell Heart Health Center, Columbus, OH
Abstract
Background—Exercise stress testing is commonly obtained after percutaneous coronary
intervention (PCI) performed for acute coronary syndromes (ACS). We compared the
relationships between exercise echocardiography and nuclear testing after ACS-related PCI on
outcomes and resource use.
Methods—Longitudinal observational study using fee-for-service Medicare claims to identify
patients undergoing outpatient exercise stress testing with imaging within 15 months after PCI
performed for ACS between 2003 and 2004.
Results—Of 63,100 patients undergoing stress testing 3 to 15 months post-PCI, 31,731 (50.3%)
underwent an exercise stress test with imaging. Among 29,279 patients undergoing exercise stress
testing with imaging, 15.5% received echocardiography. Echocardiography recipients had higher
rates of repeat stress testing (adjusted hazard ratio [HR] 2.60, CI 2.19–3.10) compared with those
undergoing nuclear imaging in the 90 days after testing, but lower rates of revascularization
(adjusted HR 0.87, CI 0.76–0.98) and coronary angiography (adjusted HR 0.88, CI 0.80–0.97).
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None of these differences persisted subsequent to 90 days after stress testing. Rates of death and
readmission for myocardial infarction rates were similar. Total Medicare payments were lower
initially after echocardiography (incremental difference $498, CI 488–507), an effect attributed
primarily to lower reimbursement for the stress test itself, but not significantly different after 14
months after testing.
Conclusions—In this study using administrative data, echocardiography recipients initially had
fewer invasive procedures but higher rates of repeat testing than nuclear testing recipients.
However, these differences between echo and nuclear testing did not persist over longer time
frames.
Exercise stress testing is commonly performed after percutaneous coronary intervention
(PCI),1 frequently accompanied with nuclear or echocardiography imaging.2 Optimal testing
approaches for patients without diagnosed coronary artery disease presenting with chest pain
have been previously examined; however, little is known about optimal stress testing
strategies in patients who have undergone revascularization.3,4 Understanding the value of
alternative testing modalities is critical, given the costs of cardiac imaging-related services
in the United States.5
To date, most evaluations of imaging have focused narrowly on test performance parameters
such as sensitivity and specificity; only recently has the research agenda been expanded to
the comparative value of imaging strategies.6 Unfortunately, studies of imaging value have
typically focused only on the testing costs, rather than the impact of testing on overall
resource use during or after episodes of care. Health care payment reforms have begun
providing incentives to facilitate transition from fee-for-service reimbursement to other
payment approaches, such as bundling or accountable care organizations. These changes
increase the importance of understanding the implications of test choices on resource use.7
We used longitudinal administrative data to compare outcomes and resource use after PCI
among patients with acute coronary syndromes (ACS), an indication for which PCI is
commonly performed.
Methods
Data sources and subjects
Medicare Provider Analysis and Review files from 2003 and 2004 were obtained for
discharges with International Classification of Diseases, Ninth Edition, Clinical
Modification (ICD-9-CM) diagnosis codes for myocardial infarction (410.xx), unstable
angina (411.1), or angina not otherwise specified (403.9). The first admission for each
patient was considered their index stay. The sample was restricted to patients (1) treated at a
short stay facility and (2) who did not have a diagnosis code reflecting a history of PCI,
coronary artery bypass grafting (CABG), or valve replacement, to generate a population of
patients treated acutely for ACS and who had not yet undergone coronary revascularization
or cardiac surgery to create a cohort treated immediately for ACS and who had not yet
undergone previous revascularization or cardiac surgery. Next, Denominator files were
obtained and used to apply additional exclusions, including (1) living outside the 50 US
States and Washington, DC; (2) not continuously enrolled in fee-for-service Medicare rather
than managed care plans (both exclusions to ensure complete measurement of subsequent
outcomes and resource use); and (3) younger than age 66 years (to allow for a full year of
claims data before the index stay). Owing to limitations on cohort size imposed by the
Centers for Medicare and Medicaid Services (CMS), patients discharged after October 14,
2004, were excluded to reduce the cohort to 1,000,000 beneficiaries.
Federspiel et al. Page 2













For this study, the cohort was further restricted to individuals admitted for ACS. For all such
patients, 2003 to 2008 inpatient, outpatient, and carrier claims were obtained to determine
whether patients received coronary revascularization (CABG or PCI) in the 30 days
subsequent to their index stay and, if performed, to characterize the revascularization
procedures performed. To ensure complete characterization of revascularization, we
excluded patients whose revascularization claims did not list Medicare as the primary payer
or for whom it was not possible to link either an inpatient or outpatient claim for the facility
charge component of the revascularization to a Carrier claim for the professional
component. Figure 1A summarizes initial data set construction, whereas online Appendix
Supplementary Table I lists the coding criteria.
Stress test population
Ultimately, 162,904 PCI recipients were included for analysis (Figure 1B). We defined a 60-
day “blackout period” after each patient’s index event because diagnostic tests during this
period may be performed for cardiac rehabilitation, staging revascularization, or functional
assessment.1 Any stress testing during this period was ignored. We excluded patients who
died (n = 19,789), readmitted for myocardial infarction (n = 2,169), or underwent repeat
revascularization or coronary angiography (n = 15,161) during the blackout period.
Among the remaining 135,785 patients, we identified patients who received an outpatient
stress test between 2 and 15 months after their index PCI event that was not preceded by
coronary angiography, repeat revascularization, or myocardial infarction readmission. Each
patient’s first eligible stress test was included in the analysis. We excluded patients (1)
receiving an inpatient stress test (based on place of service codes) because of an inability to
identify pharmacologic stress agents on inpatient claims, (2) receiving positron emission
tomography or magnetic resonance imaging because these tests were rarely performed, (3)
who were coded as having both stress nuclear and echocardiography procedures on the same
day, (4) receiving an electrocardiogram-only test, and (5) who received pharmacologic stress
testing, as pharmacologic testing was overwhelmingly (~98%) performed with nuclear
imaging. Ultimately, 29,279 eligible patients were included in the comparison of
echocardiographic and nuclear stress testing.
Treatment and outcome definitions
The use of stress testing after PCI was identified by Healthcare Common Procedure Coding
System (HCPCS) codes. Electrocardiogram stress and nuclear imaging procedures
performed within 1 day of each other were considered a single nuclear test; similarly,
electrocardiogram stress and echocardiographic testing performed on the same day were
considered a single echocardiography test.
We considered 6 outcomes: all-cause mortality, readmission for myocardial infarction,
coronary revascularization, coronary angiography, additional stress testing, and Medicare
payments. The number and dates of coronary angiography and coronary revascularization
(either PCI or CABG) procedures after stress testing were identified using ICD-9-CM
procedure, HCPCS, and diagnosis-related grouping (DRG) codes. Medicare payments were
obtained by measuring total payments on inpatient, outpatient, and carrier claims occurring
on and/or after the stress testing date. In addition to overall payments, we also evaluated
payments stratified by whether the claim included a stress test–related line item.
Other covariates
The presence of comorbid conditions was measured using Elixhauser criteria, based on
diagnosis codes recorded on claims in the year preceding the index ACS event.8 Because
diagnosis codes on outpatient and carrier claims are not always validated, comorbidities
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recorded on these claims were only included if they were documented on 2 or more claims
for dates of service 30 or more days apart.9 Percutaneous coronary intervention facility
characteristics were obtained from Medicare Provider of Services Files. Small area
socioeconomic data, measured at the ZIP code level, were obtained from the 2000 US
Census.10
Statistical analysis
We present percentages and medians with interquartile ranges (IQRs) for categorical and
continuous variables, respectively. Patient characteristics were compared between imaging
modalities using χ2 tests for categorical and Kruskal-Wallis tests for continuous variables.
A propensity score model, estimating the probability of receiving echocardiography versus
nuclear imaging, was constructed using a logistic regression. Covariates (online Appendix
Supplementary Table I and online Appendix Supplementary Figure 2) were selected based
on factors that may confound the relationship between imaging modality and outcomes11
including the following: demographics, socioeconomic characteristics, PCI and PCI facility
characteristics, time from PCI to stress testing, Medicare payments in the 60 days preceding
stress testing, and whether the patient received care for comorbid conditions in the year
before their index stay. Inverse probability weighting was used to adjust for differences in
baseline characteristics.12 We evaluated covariate balance before and after inverse
probability weighting using standardized differences.13
All time-to-event outcomes were analyzed treating death as a competing risk, and end of
fee-for-service claims availability was a censoring event. For the coronary angiography and
revascularization outcomes, readmission for myocardial infarction was considered an
additional competing risk; for repeat stress testing, readmission for myocardial infarction,
revascularization, and coronary angiography were all considered competing events.
Unadjusted results were portrayed using cumulative incidence curves, and bivariate tests of
association were performed between imaging modalities using Gray test.14 Adjusted hazard
ratios (HRs) were generated using cause-specific Cox proportional hazards models, adjusted
using inverse probability weighting. To determine whether imaging modality affected short-
term processes of care differently than long-term processes, we constructed models with
interaction terms between imaging modality and time (a binary indicator for time being
within 90 days after testing). The 90-day threshold was specified a priori to distinguish
“short-term” and “long-term” processes of care; however, we conducted sensitivity analyses
with thresholds set at 30-day increments between 30 and 180 days. We also evaluated an
alternative model formulation modeling cumulative incidence in the presence of competing
risks, rather than cause-specific hazards.15
CMS payments were estimated in a partitioned framework to allow for censoring caused by
differential follow-up length.16 A person-period data set was constructed using 1 period for
the day of stress testing followed by up to 40 additional 30-day periods. Each patient’s
resource use was included for all periods in which they were completely observed. Adjusted
estimates of the difference in cost were constructed using inverse propensity weighted
(IPW)–adjusted linear models; clustered SDs were used to account for within-person
correlation in the person-period observations.17
Statistical analyses were conducted using SAS version 9.2 (SAS Institute, Inc, Cary, NC), R
version 2.11.1 (R Foundation, Vienna, Austria), and Stata/MP version 12.1 (Statacorp,
College Station, TX) with a 2-sided α level of .05 prespecified as significant. The University
of North Carolina at Chapel Hill institutional review board granted a waiver of the informed
consent and authorization for this study. This study was supported by the Agency for
Healthcare Research and Quality and the National Institutes of Health. The authors are
Federspiel et al. Page 4













solely responsible for the design and conduct of this study, study analyses, the drafting and
editing of the manuscript, and its final contents.
Results
Characteristics of study population
Of 29,279 eligible patients (Figure 1), 4,542 (15.5%) received exercise echocardiography.
Patients receiving exercise echocardiography had fewer comorbid conditions (eg, heart
failure, pulmonary circulatory disease, peripheral vascular disease, chronic lung disease, and
diabetes mellitus) than those receiving exercise nuclear testing (Table I). Patients receiving
exercise echocardiography were also more likely to have received a drug-eluting (rather than
bare-metal) coronary stent during their index event. There were no differences in the rates of
the various ACS diagnoses. Echocardiography patients had received PCI during their index
event in smaller facilities.
Propensity score model
Among echocardiography recipients, propensity scores ranged from 0.02 to 0.51, with
median 0.16 (IQR 0.12–0.25); among nuclear imaging recipients, propensity scores ranged
from ranged from 0.02 to 0.51, with a median of 0.13 (IQR 0.10–0.17) (online Appendix
Supplementary Figure 1). Virtually all (99.9%) observations fell in the region of common
support of the propensity score, suggesting that the analysis does not entail comparison of
distinct populations. The initially selected logistic regression model, constructed without
interactions or polynomial terms, produced excellent covariates balance, evidenced by
reductions in standardized differences after inverse probability weighting (online Appendix
Supplementary Figure 2).
Outcomes and resource use
Follow-up data were available for a median of 1,666 days after stress testing (IQR 1,446–
1,854 days) and were identical for echocardiography and nuclear testing (1,667 vs 1,666
days, P = .81). In unadjusted analyses, patients receiving exercise echocardiography had a
lower incidence of diagnostic angiography and repeat revascularization after testing than did
exercise nuclear patients but higher rates of repeat stress testing (Figure 2). The incidence of
coronary angiography was higher for nuclear than echocardiography recipients at 90 days
(14.9% vs 12.7%) and 3 years (34.8% vs 32.0%); nuclear patients also had a higher
incidence of repeat revascularization at both 90 days (9.0% vs 7.7%) and 3 years (20.0% vs
18.7%). Echocardiography patients had more repeat stress tests at 90 days after testing
(5.0% vs 1.8%) and at 3 years (60.3% vs 55.7%). Of particular note was a sharp uptick in
repeat stress test usage approximately 1 year after stress testing, suggesting common use of
scheduled annual stress testing.
In adjusted analyses (Table II), overall rates of coronary angiography were lower in exercise
echocardiography recipients (adjusted HR 0.93, 95% CI 0.88–0.98), but rates of repeat stress
testing (adjusted HR 1.07, 95% CI 1.03–1.12) were higher. Differences in rates of death,
admission for subsequent myocardial infarction, and repeat revascularization were not
statistically significant. After the first 90 days after testing, rates of all events were equal in
patients tested with echocardiography and nuclear imaging. Rates of death and admission for
myocardial infarction were not significantly different overall. Owing to the very low (<1%)
incidence of both outcomes in the 90 days following stress testing, results are not reported
separately by time cut point for these outcomes. Results were consistent across a range of
cut points of 30 to 180 days after stress testing (online Appendix Supplementary Table I)
and when estimated using competing risk models (online Appendix Supplementary Table
II).
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Without adjustment, exercise echocardiography was associated with lower total Medicare
payments than exercise nuclear on the day of stress testing (incremental difference $-497.61,
CI −506.89 to −488.32); the cumulative difference between exercise echocardiography and
exercise nuclear grew throughout the study period (Figure 3). After IPW adjustment, the
difference in payments on day of test was comparable with the unadjusted estimate
(incremental difference −$499.42, CI −510.34 to −488.51); however, the cumulative
payment difference between echocardiography and nuclear imaging decreased over time and
was no longer statistically significant at 14 months after stress testing. Stratifying payments
into those for stress testing versus all other services illustrated that stress testing–related
payments were lower for exercise echocardiography recipients, but there was no significant
difference in payments for all other services (Figure 4). The $499.42 difference in overall
payments observed on the day of initial stress test was explained by differences in spending
for stress testing–related services ($509.04). The difference in cumulative stress testing–
related payments grew smaller during the first year after the initial testing but increased in
magnitude for time points subsequent to 1 year.
Discussion
In a national cohort of patients older than 65 years with ACS undergoing exercise stress
testing with imaging after coronary stenting, patients tested with echocardiography and
nuclear imaging had similar rates of death and myocardial infarction after adjustment for
baseline differences; however, the pattern of resource use after stress testing differed.
Echocardiography recipients had higher short-term rates of repeat stress testing but lower
rates of invasive testing and intervention. Moreover, costs differed depending on the time
interval considered, with total CMS payments being lower among echocardiography
recipients immediately after testing, but not significantly different after 14 months after
testing, with this difference explained by the difference in charges from the initial stress test.
Although the baseline clinical characteristics of patients tested with echocardiography
versus nuclear imaging demonstrated only modest differences, patients tested with
echocardiography had a lower burden of risk factors than those tested with nuclear testing,
including lower rates of most comorbidities. Such differences have been suggested in
previous research but have generally not been carefully examined despite their potential to
skew conclusions based on Bayesian principles.18,19 We attempted to adjust for confounding
using propensity score techniques.
The results observed in our study may reflect differences in test characteristics between the
2 modalities. When compared with nuclear imaging, echocardiography has been
demonstrated to be a less sensitive but more specific test because wall motion abnormalities
are “further down the ischemic cascade” than ischemia detectable by nuclear imaging.20,21
These performance characteristics may contribute to lower short-term use of coronary
angiography and revascularization in post-PCI patients receiving echocardiographic testing,
a finding that has been previously demonstrated for patients without a history of coronary
artery disease.3 The dissipation of this effect after stress testing may indicate how quickly
patients move through an episode of care.
Stress echocardiography resulted in higher short-term rates of repeat stress testing than did
nuclear imaging. Several factors may explain this finding. Because stress echocardiography
studies are sometimes viewed as more challenging to interpret than nuclear images, higher
short-term rates of repeat testing may reflect a higher rate of equivocal studies. Because
physician confidence in test results is inversely correlated with rates of additional test use,
our findings may also reflect lower physician comfort with echocardiography findings.22
Finally, nuclear stress testing may be viewed as having a longer “warranty period” (ie, the
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period after a normal study in which the patient is viewed as being highly unlikely to have
recurrent ischemia) than echocardiography.23 Because the effect attributed to
echocardiography was stronger in the short term than the long term, an initial lack of
confidence or clarity in test results (which would drive greater use of immediate repeat
testing) seems a more relevant factor than differences in warranty period.
Most outpatient stress testing after PCI is used either to assess symptoms suggestive of
recurrent/progressive myocardial ischemia or to screen asymptomatic patients. Evidence
suggests that revascularization procedures in patients with stable chest pain may improve
quality of life, but generally do not improve survival or prevent myocardial infarction.24
Thus, our finding of similar rates of death and myocardial infarction (regardless of stress test
imaging modality used) is consistent with the overall good prognosis of this patient
population. Furthermore, documentation of similar clinical outcomes makes differences in
resource use a more important consideration. We found that stress echocardiography was
associated with lower CMS payments on the day of, and up to 14 months after, initial
testing. After 14 months, the difference in CMS payments was no longer significant. The
difference in test reimbursement for echocardiography versus nuclear imaging during the
period under study (2003–2005) appeared to be the primary determinant of cost difference
rather than downstream service use, suggesting that equalization of reimbursement for
echocardiography and nuclear testing would result in similar long-term costs to payers. The
pattern also suggests that careful attention to decisions regarding invasive workup shortly
after stress testing may be a promising approach to controlling cost without affecting
outcome, in light of the similarities in death and myocardial infarction rates.
In aggregate, our findings illustrate complexities when evaluating cardiac imaging and using
results to inform clinical practice and health policy. The differences observed in the
populations chosen for each test suggest that careful attention to the risk profile of cohorts
under study is needed to accurately compare testing strategies. This assessment may be
accomplished through careful statistical adjustment or by randomization, as has been done in
a handful of studies, including the recently completed What Is the Optimal Method for
Ischemia Evaluation in Women (WOMEN) trial4 and the ongoing PROspective Multicenter
Imaging Study for Evaluation of Chest Pain (PROMISE) study. The differences in
downstream testing and procedure rates but similar rates of outcomes—even after statistical
adjustment for clinical and other characteristics—demonstrate the need to examine
parameters other than diagnostic and prognostic accuracy when evaluating testing strategies.
In general, outcome studies for cardiac imaging should consider the short- and long-term
impact on processes of care and resource use.6 This effort may be complicated by the
potential for “tradeoffs” associated with test choice, as observed here. Furthermore, length
of follow-up is also an important consideration. If only test reimbursement is considered,
exercise echocardiography might appear less expensive, whereas if the longer term is
considered, there may be little difference between imaging modalities. As payment models
transition toward payment for episodes of care rather than on a fee-for-service basis, episode
length (as well as testing during the 60-day blackout period excluded from this study) may
play an important role in what are perceived to be optimal testing strategies.
Our study had several limitations. First, the study cohort was limited to patients older than
65 years and enrolled in fee-for-service Medicare. The results may not apply to other
populations. This study focuses on the use of stress testing in outpatient settings, and results
may not apply to inpatient stress testing. There is potential for residual confounding between
imaging modality and outcome because of unmeasured patient characteristics. Although we
were able to measure whether patients received drug-eluting stents and whether they
underwent a multivessel procedure, detailed angiographic characteristics were not available.
Finally, we lacked detailed clinical data (eg, symptoms) at the time of stress testing. As a
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result, we cannot identify the indication for which the stress test was ordered and, therefore,
cannot examine stress testing appropriateness.
In summary, the choice of using echocardiography versus nuclear imaging in conjunction
with exercise stress testing in patients who have received PCI for ACS results in a different
pattern of subsequent care. Echocardiography recipients receive fewer invasive procedures
in the short term but face increased use of repeat stress testing. Conversely, nuclear stress
testing results in higher rates of downstream coronary angiography and repeat
revascularization. These differences in posttesting patterns of care highlight that analyses of
imaging value must consider not only unit cost and performance characteristics but also how
initial testing choice affects outcomes and processes of care. Such considerations will be
relevant for policy makers and providers in designing new reimbursement schemes for
patients with ACS.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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A and B, A cohort selection diagram illustrating a process by which study cohort was
identified. Included patients were those receiving an outpatient exercise nuclear or
echocardiography stress test not preceded by another cardiac event.
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Unadjusted outcomes by stress test imaging modality. Curves illustrate unadjusted
cumulative incidence of outcomes, based on time since stress testing. P values are for
comparison of nuclear versus echocardiography using Gray test.
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Unadjusted and adjusted incremental total Medicare payments. A comparison of exercise
echocardiography and exercise nuclear. Dotted lines indicate incremental difference in cost
accruing during the day of initial stress testing.
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Inverse propensity weighted–adjusted cumulative incremental costs. A comparison of
echocardiography and nuclear imaging with costs stratified by stress test–related versus all
other.
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Table I
Selected baseline patient characteristics
Overall (n = 29,279)
Exercise nuclear (n =
24,737)
Exercise echo (n =
4542) P
Demographics
 Age (y), median (25th–75th percentile) 74.0 (70.0–78.0) 74.0 (70.0–78.0) 74.0 (70.0–78.0) .45
 Female gender (%) 42.5 42.6 42.3 .71
 Nonwhite race (%) 6.2 6.1 6.8 .07
 State Medicaid buy-in (%) 6.9 6.8 7.3 .27
 ZIP code characteristics (%)
  Household income ($10000s), median (25th–
75th percentile)
4.1 (3.4–5.3) 4.1 (3.4–5.3) 4.2 (3.4–5.4) .02
  Percentage living in poverty, median (25th–75th
percentile)
8.8 (5.2–13.8) 8.8 (5.1–13.8) 9.0 (5.5–13.8) .02
  Percentage with college education, median
(25th–75th percentile)
26.9 (19.3–39.6) 26.7 (19.1–39.2) 28.0 (20.1–41.4) <.001
 Census region (%) <.001
  New England 5.6 5.6 6.1
  Middle Atlantic 14.2 14.7 11.4
  East North Central 20.2 20.6 18.5
  West North Central 10.1 9.6 12.6
  South Atlantic 21.5 23.3 11.8
  East South Central 6.4 6.9 3.7
  West South Central 8.4 8.3 8.6
  Mountain 5.1 4.4 8.6
  Pacific 8.5 6.7 18.8
Clinical characteristics (%)
 ACS diagnosis .23
  UA 45.1 45.0 45.6
  NSTEMI 25.7 25.9 24.7
  STEMI 29.2 29.1 29.7
 Multivessel PCI 19.5 19.5 19.4 .82
 Stent insertion 97.1 97.1 96.8 .22
 Any DES insertion 45.2 44.9 47.0 .01
 Any BMS insertion 53.5 53.9 51.1 <.001
 Selected comorbidities
  Heart failure 12.6 13.0 10.5 <.001
  Valve disease 8.1 8.1 7.7 .31
  Pulmonary circulation disease 2.0 2.0 1.6 .04
  Peripheral vascular disease 12.7 12.9 11.6 .02
  Neurologic disease 2.5 2.5 2.2 .25
  Chronic lung disease 19.1 19.4 17.1 <.001
  Diabetes: uncomplicated 21.7 22.1 19.7 <.001
  Diabetes: complicated 5.3 5.5 4.2 <.001
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Overall (n = 29,279)
Exercise nuclear (n =
24,737)
Exercise echo (n =
4542) P
  Hypothyroidism 12.4 12.4 12.4 .97
  Renal failure 2.8 2.8 2.6 .33
  Liver disease 1.7 1.8 1.3 .02
  Obesity 5.8 5.9 5.0 .02
  Hypertension 77.3 77.7 75.1 <.001
  Recent stroke 6.6 6.7 6.0 .06
Facility characteristics
 Hospital ownership (%) .05
  Nonprofit 80.6 80.5 81.3
  For-profit 10.1 10.3 9.1
  Government 9.3 9.2 9.6
 Major medical school affiliation (%) 32.0 31.9 32.7 .27
 No. of CMS-authorized beds, median (25th–75th
percentile)
411 (285–597) 420 (289–606) 375 (269–537) <.001
Prestress test characteristics
 Medicare payments 1–60 d pretest ($), median
(25th–75th percentile)
274 (102–687) 276 (104–691) 258 (92–667) <.001
 Calendar time (d) (1 = 3/1/2003), median (25th–
75th percentile)
408 (247–598) 402 (246–598) 430 (257–600) <.001
 Time from PCI to stress test (d), median (25th–75th
percentile)
180 (112–273) 181 (113–273) 177 (107–274) .04
 Stress test during blackout period (%) 20.2 19.9 21.8 .005
NSTEMI, Non–ST-elevation myocardial infarction; STEMI, ST-elevation myocardial infarction; UA, unstable angina; DES, drug-eluting stent;
BMS, bare-metal stent.
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Table II
Unadjusted and adjusted cause-specific hazards models (echocardiography vs nuclear imaging)
Unadjusted model IPW model
Entire study period
 Death 0.88 (0.81–0.96) 0.99 (0.90–1.09)
 Myocardial infarction 0.96 (0.84–1.09) 1.01 (0.87–1.17)
 Revascularization 0.93 (0.87–0.99) 0.94 (0.87–1.01)
 Diagnostic angiography 0.91 (0.87–0.96) 0.93 (0.88–0.98)
 Second stress test 1.12 (1.07–1.16) 1.07 (1.03–1.12)
Days 1–90 after stress testing
 Revascularization 0.84 (0.75–0.94) 0.87 (0.76–0.98)
 Diagnostic angiography 0.85 (0.78–0.93) 0.88 (0.80–0.97)
 Second stress test 2.78 (2.37–3.26) 2.60 (2.19–3.10)
Days 91+ after stress testing
 Revascularization 0.98 (0.90–1.07) 0.99 (0.90–1.08)
 Diagnostic angiography 0.95 (0.89–1.01) 0.96 (0.89–1.03)
 Second stress test 1.06 (1.02–1.11) 1.03 (0.98–1.07)
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